MedPath

A phase II trial of TS-1/CDDP as neoadjuvant chemotherapy against resectable gastric cancer.

Not Applicable
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000004466
Lead Sponsor
Toho University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
110
Inclusion Criteria

Not provided

Exclusion Criteria

1.Metachronous or synchronous multiple cancer 2.Pregnant or in lactation. 3.Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath